Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (251)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
116
1.950
 Why?
Thyroidectomy
13
2019
61
1.800
 Why?
Parathyroidectomy
8
2018
46
1.270
 Why?
Thyroid Diseases
7
2019
28
1.270
 Why?
Parathyroid Neoplasms
5
2015
27
1.070
 Why?
Thyroid Gland
8
2017
79
1.060
 Why?
Parathyroid Hormone
8
2019
149
0.940
 Why?
Adenoma
4
2017
113
0.930
 Why?
Vitamin D Deficiency
5
2019
45
0.930
 Why?
Vitamin D
4
2015
89
0.800
 Why?
Fluorodeoxyglucose F18
6
2013
188
0.730
 Why?
Positron-Emission Tomography
7
2013
303
0.710
 Why?
Radiopharmaceuticals
7
2015
205
0.700
 Why?
Carcinoma, Papillary
4
2017
51
0.700
 Why?
Ambulatory Surgical Procedures
4
2014
52
0.670
 Why?
Hyperparathyroidism, Primary
4
2018
35
0.650
 Why?
Iodine Radioisotopes
4
2015
35
0.600
 Why?
Hyperparathyroidism
2
2015
31
0.580
 Why?
Megestrol Acetate
2
2007
17
0.520
 Why?
Parathyroid Diseases
2
2016
5
0.520
 Why?
Bone Density Conservation Agents
2
2007
75
0.500
 Why?
Nursing Homes
2
2007
112
0.500
 Why?
Incidental Findings
3
2013
43
0.470
 Why?
Proton Pump Inhibitors
1
2015
86
0.460
 Why?
Diphosphonates
1
2015
92
0.460
 Why?
Academic Medical Centers
2
2012
149
0.450
 Why?
Thyroglobulin
2
2013
7
0.440
 Why?
Parathyroid Glands
5
2018
20
0.420
 Why?
Carcinoma, Medullary
2
2010
12
0.420
 Why?
Aged
20
2017
10109
0.420
 Why?
Middle Aged
26
2017
13014
0.410
 Why?
Hypothyroidism
2
2011
57
0.380
 Why?
Male
31
2019
26696
0.370
 Why?
Retrospective Studies
14
2019
6578
0.370
 Why?
Calcitonin
2
2010
30
0.360
 Why?
Postoperative Complications
5
2018
1066
0.360
 Why?
Carcinoma
2
2012
137
0.340
 Why?
Humans
45
2019
52336
0.340
 Why?
Algorithms
1
2013
668
0.330
 Why?
Thyroid Nodule
3
2017
31
0.320
 Why?
Female
30
2019
28105
0.310
 Why?
Weight Loss
2
2009
249
0.300
 Why?
Appetite Stimulants
1
2007
5
0.280
 Why?
Aged, 80 and over
10
2017
3391
0.270
 Why?
Cachexia
1
2007
28
0.270
 Why?
Teriparatide
1
2007
10
0.270
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.250
 Why?
Calcium
3
2018
375
0.250
 Why?
Hypocalcemia
2
2016
13
0.250
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.250
 Why?
Phenylurea Compounds
2
2015
18
0.240
 Why?
Hormones
1
2005
59
0.240
 Why?
Osteoporosis
1
2007
162
0.240
 Why?
Quinolines
2
2015
44
0.240
 Why?
Transcriptional Activation
1
2005
128
0.240
 Why?
Pituitary Gland
1
2005
88
0.230
 Why?
Receptors, Estrogen
1
2005
132
0.230
 Why?
Interleukin-6
1
2005
278
0.220
 Why?
NF-kappa B
1
2005
328
0.210
 Why?
Biopsy, Fine-Needle
5
2011
107
0.210
 Why?
Protein Kinase Inhibitors
2
2015
230
0.210
 Why?
Illinois
2
2013
11
0.200
 Why?
Treatment Outcome
8
2015
5407
0.190
 Why?
Adult
13
2017
14139
0.180
 Why?
Gene Expression Regulation
1
2005
1006
0.170
 Why?
Aging
1
2005
708
0.170
 Why?
Young Adult
7
2015
4319
0.160
 Why?
Follow-Up Studies
3
2013
2268
0.160
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.160
 Why?
Postoperative Period
3
2015
170
0.150
 Why?
Preoperative Care
2
2018
172
0.140
 Why?
Vitamins
2
2018
64
0.140
 Why?
Patient Discharge
3
2016
317
0.140
 Why?
Intraoperative Complications
1
2019
112
0.140
 Why?
Insulin Resistance
2
2009
277
0.140
 Why?
Prospective Studies
2
2013
2428
0.130
 Why?
United States
5
2015
5182
0.130
 Why?
Antineoplastic Agents
2
2015
1222
0.130
 Why?
Predictive Value of Tests
3
2015
943
0.130
 Why?
Reoperation
1
2018
465
0.130
 Why?
Incidence
2
2011
1059
0.120
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
25
0.120
 Why?
Adolescent
5
2015
6692
0.120
 Why?
Creatinine
1
2015
149
0.120
 Why?
Lymph Nodes
1
2017
252
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
52
0.120
 Why?
Costs and Cost Analysis
2
2014
95
0.120
 Why?
Disease Progression
3
2015
870
0.120
 Why?
Molecular Targeted Therapy
1
2015
134
0.110
 Why?
Diagnosis, Differential
6
2018
1044
0.110
 Why?
Ambulatory Care
1
2016
239
0.110
 Why?
Neoplasm Metastasis
2
2015
240
0.110
 Why?
Hospitals, University
1
2014
75
0.110
 Why?
Child, Preschool
2
2013
4030
0.110
 Why?
Sensitivity and Specificity
2
2013
879
0.100
 Why?
Liver
2
2009
1159
0.100
 Why?
Exercise
2
2009
548
0.100
 Why?
Drug Administration Schedule
1
2013
372
0.100
 Why?
Hospitals, Teaching
1
2013
53
0.100
 Why?
Technetium
1
2012
8
0.100
 Why?
Preoperative Period
1
2012
46
0.100
 Why?
Administration, Oral
1
2013
451
0.100
 Why?
Patient Compliance
1
2013
230
0.100
 Why?
Radionuclide Imaging
1
2012
107
0.100
 Why?
Clinical Competence
2
2018
404
0.100
 Why?
Outpatients
1
2013
125
0.100
 Why?
Hospital Charges
1
2012
46
0.100
 Why?
Struma Ovarii
1
2012
5
0.100
 Why?
Tumor Burden
1
2012
136
0.100
 Why?
Cost Savings
1
2012
58
0.090
 Why?
Prognosis
3
2015
2094
0.090
 Why?
Ovariectomy
1
2012
113
0.090
 Why?
Child
3
2013
7157
0.090
 Why?
Immunohistochemistry
2
2012
985
0.090
 Why?
Obesity
2
2009
1162
0.090
 Why?
Chromogranin A
1
2010
5
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1377
0.080
 Why?
Radiation Monitoring
1
2010
7
0.080
 Why?
Inpatients
1
2011
205
0.080
 Why?
Checklist
1
2010
40
0.080
 Why?
Fatal Outcome
1
2010
196
0.080
 Why?
Radiosurgery
1
2011
131
0.080
 Why?
Databases, Factual
1
2013
706
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
38
0.080
 Why?
Ultrasonography
4
2015
424
0.080
 Why?
Intra-Abdominal Fat
1
2009
21
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
General Surgery
1
2010
106
0.080
 Why?
Occupational Exposure
1
2010
111
0.070
 Why?
Blastomycosis
1
2008
31
0.070
 Why?
Receptors, Thyrotropin
1
2007
6
0.070
 Why?
Symporters
1
2007
15
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Time Factors
3
2015
2957
0.070
 Why?
Ovarian Neoplasms
1
2012
459
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Whole Body Imaging
1
2007
26
0.070
 Why?
Severity of Illness Index
1
2011
1021
0.070
 Why?
Adiposity
1
2009
143
0.070
 Why?
DNA, Neoplasm
1
2007
146
0.070
 Why?
Calcifediol
1
2006
8
0.070
 Why?
Practice Management, Medical
1
2006
10
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Medical Audit
1
2006
21
0.070
 Why?
Promoter Regions, Genetic
2
2007
474
0.070
 Why?
Drug Utilization Review
1
2006
22
0.070
 Why?
Drug Monitoring
1
2006
83
0.060
 Why?
Head
1
2006
70
0.060
 Why?
Cross-Sectional Studies
2
2014
1676
0.060
 Why?
Gene Expression Regulation, Neoplastic
1
2010
858
0.060
 Why?
Geriatrics
1
2006
47
0.060
 Why?
Otolaryngology
1
2006
61
0.060
 Why?
Body Mass Index
2
2009
689
0.060
 Why?
Neck
1
2006
97
0.060
 Why?
Proportional Hazards Models
1
2007
443
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
10
0.060
 Why?
Freezing
1
2005
16
0.060
 Why?
Faculty, Medical
1
2006
91
0.060
 Why?
Arkansas
2
2014
2028
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Fractures, Bone
1
2006
107
0.060
 Why?
Survival Analysis
1
2007
671
0.060
 Why?
DNA Primers
1
2005
209
0.060
 Why?
Reproducibility of Results
3
2017
1214
0.060
 Why?
Internship and Residency
1
2010
449
0.060
 Why?
HeLa Cells
1
2005
263
0.060
 Why?
Base Sequence
1
2005
648
0.060
 Why?
Nuclear Proteins
1
2005
251
0.050
 Why?
Protein Binding
1
2005
680
0.050
 Why?
Infant
1
2012
3684
0.050
 Why?
ROC Curve
2
2015
251
0.050
 Why?
Patient Selection
2
2018
259
0.050
 Why?
Intraoperative Period
2
2015
46
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
594
0.050
 Why?
Tongue Diseases
1
2001
7
0.050
 Why?
Choristoma
1
2001
24
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1162
0.040
 Why?
Thalidomide
1
2002
377
0.040
 Why?
Glucagon
2
2009
24
0.040
 Why?
Cohort Studies
2
2015
1532
0.040
 Why?
Monitoring, Intraoperative
1
2019
54
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
47
0.040
 Why?
Risk Factors
1
2006
3872
0.040
 Why?
Pilot Projects
2
2010
719
0.030
 Why?
Methylene Blue
1
2017
7
0.030
 Why?
Lymphatic System
1
2017
12
0.030
 Why?
Animals, Genetically Modified
1
2017
52
0.030
 Why?
Societies, Medical
1
2018
200
0.030
 Why?
Coloring Agents
1
2017
68
0.030
 Why?
Mice, Inbred Strains
1
2017
165
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
81
0.030
 Why?
Insulin
2
2009
481
0.030
 Why?
Recurrence
1
2018
672
0.030
 Why?
Lymphatic Metastasis
1
2017
212
0.030
 Why?
Bone Density
1
2018
399
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
58
0.030
 Why?
Brachial Plexus
1
2015
12
0.030
 Why?
Endocrinology
1
2015
11
0.030
 Why?
Axilla
1
2015
92
0.030
 Why?
Hematoma
1
2015
65
0.030
 Why?
Transplantation, Autologous
1
2015
488
0.030
 Why?
Neoplasm Staging
1
2015
770
0.020
 Why?
Hernia, Abdominal
1
2012
4
0.020
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
30
0.020
 Why?
Mutation
1
2017
1351
0.020
 Why?
Ribs
1
2010
16
0.020
 Why?
Thoracotomy
1
2010
33
0.020
 Why?
Neck Dissection
1
2010
29
0.020
 Why?
Mediastinal Neoplasms
1
2010
18
0.020
 Why?
Hypercalcemia
1
2010
34
0.020
 Why?
Feasibility Studies
1
2011
402
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
70
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Hospitalization
1
2014
732
0.020
 Why?
Glucose Tolerance Test
1
2009
61
0.020
 Why?
Prevalence
1
2012
1007
0.020
 Why?
Adiponectin
1
2009
46
0.020
 Why?
Postmenopause
1
2009
82
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
236
0.020
 Why?
Absorptiometry, Photon
1
2009
162
0.020
 Why?
Eye
1
2008
25
0.020
 Why?
Bone Neoplasms
1
2010
184
0.020
 Why?
Iodine
1
2007
12
0.020
 Why?
Methylation
1
2007
126
0.020
 Why?
Body Weight
1
2009
522
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
643
0.020
 Why?
Overweight
1
2009
224
0.020
 Why?
Multiple Myeloma
1
2002
3049
0.020
 Why?
Current Procedural Terminology
1
2006
11
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Office Visits
1
2006
45
0.020
 Why?
Mice
1
2017
5965
0.020
 Why?
Polymerase Chain Reaction
1
2007
460
0.020
 Why?
Blood Glucose
1
2009
471
0.020
 Why?
Genetic Predisposition to Disease
1
2009
528
0.020
 Why?
Risk Assessment
1
2010
1323
0.010
 Why?
Lung
1
2008
502
0.010
 Why?
Muscle, Skeletal
1
2009
809
0.010
 Why?
Thyroid Function Tests
1
2002
27
0.010
 Why?
Thyrotropin
1
2002
49
0.010
 Why?
Animals
1
2017
13523
0.010
 Why?
Airway Obstruction
1
2001
50
0.010
 Why?
Deglutition Disorders
1
2001
80
0.010
 Why?
Clinical Trials as Topic
1
2002
468
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (251) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department